Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.18 - $0.86 $3,600 - $17,200
20,000 New
20,000 $6,000
Q1 2022

May 16, 2022

SELL
$0.6 - $1.06 $9,660 - $17,066
-16,100 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.85 - $1.4 $4,675 - $7,699
-5,500 Reduced 25.46%
16,100 $14,000
Q3 2021

Nov 12, 2021

BUY
$1.33 - $1.77 $4,389 - $5,841
3,300 Added 18.03%
21,600 $29,000
Q2 2021

Aug 06, 2021

SELL
$1.41 - $1.94 $10,575 - $14,550
-7,500 Reduced 29.07%
18,300 $26,000
Q1 2021

May 14, 2021

BUY
$1.61 - $2.77 $18,032 - $31,024
11,200 Added 76.71%
25,800 $42,000
Q4 2020

Feb 12, 2021

SELL
$1.55 - $2.24 $6,045 - $8,736
-3,900 Reduced 21.08%
14,600 $27,000
Q3 2020

Nov 13, 2020

SELL
$1.91 - $3.08 $30,560 - $49,280
-16,000 Reduced 46.38%
18,500 $38,000
Q2 2020

Aug 13, 2020

BUY
$1.97 - $3.98 $35,854 - $72,436
18,200 Added 111.66%
34,500 $95,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.65 $5,082 - $6,930
-4,200 Reduced 20.49%
16,300 $22,000
Q2 2019

Aug 20, 2019

BUY
$1.39 - $2.03 $5,838 - $8,526
4,200 Added 25.77%
20,500 $34,000
Q1 2019

May 15, 2019

BUY
$1.39 - $1.71 $1,945 - $2,394
1,400 Added 9.4%
16,300 $24,000
Q3 2018

Nov 14, 2018

BUY
$1.86 - $2.18 $27,714 - $32,482
14,900 New
14,900 $31,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.